Patents by Inventor Molly Morag Stevens

Molly Morag Stevens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200116725
    Abstract: Aspects of the present disclosure relate to methods and compositions useful for in vivo and/or in vitro profiling of environmental triggers (e.g., enzyme activity, pH or temperature). In some embodiments, the disclosure provides methods of in vivo enzymatic processing of exogenous molecules followed by detection of nanocatalysts as representative of the presence of active enzymes (e.g., proteases) associated with a disease, for example, cancer or infection. In some embodiments, the disclosure provides compositions and methods for production of in vivo sensors comprising nanocatalysts.
    Type: Application
    Filed: October 16, 2019
    Publication date: April 16, 2020
    Applicants: Massachusetts Institute of Technology, President and Fellows of Harvard College
    Inventors: Sangeeta N. Bhatia, Molly Morag Stevens, Colleen Loynachan, Ava Soleimany
  • Patent number: 9494524
    Abstract: The present invention relates to compositions, assay devices, kits and methods for detecting the presence, amount and/or activity of an analyte in a sample. In particular, the present invention relates to the detection of enzymes. The present invention also relates to methods of diagnosing diseases associated with dysregulation of enzymes, screening for modulators of enzymatic activity, candidate antimicrobial peptides and toxins.
    Type: Grant
    Filed: March 15, 2011
    Date of Patent: November 15, 2016
    Inventors: Morgan Mager, Erik Daniel Aili, Molly Morag Stevens
  • Patent number: 9393097
    Abstract: The present invention relates to a layered fibrous construct for use as a scaffold for repairing or replacing cartilage or cartilage-like tissue, and a process for the production thereof.
    Type: Grant
    Filed: December 16, 2011
    Date of Patent: July 19, 2016
    Inventors: Seth Dylan McCullen, Molly Morag Stevens, Helen Autefage
  • Publication number: 20130338791
    Abstract: The present invention relates to a layered fibrous construct for use as a scaffold for repairing or replacing cartilage or cartilage-like tissue, and a process for the production thereof.
    Type: Application
    Filed: December 16, 2011
    Publication date: December 19, 2013
    Inventors: Seth Dylan McCullen, Molly Morag Stevens, Helen Autefage
  • Publication number: 20130203073
    Abstract: The present invention relates to compositions, assay devices, kits and methods for detecting the presence, amount and/or activity of an analyte in a sample. In particular, the present invention relates to the detection of enzymes. The present invention also relates to methods of diagnosing diseases associated with dysregulation of enzymes, screening for modulators of enzymatic activity, candidate antimicrobial peptides and toxins.
    Type: Application
    Filed: March 15, 2011
    Publication date: August 8, 2013
    Applicant: Imperial Innovations Limited
    Inventors: Morgan Mager, Erik Daniel Aili, Molly Morag Stevens
  • Patent number: 8476402
    Abstract: The present invention relates to a novel carbohydrate lactone, functionalized aliphatic polyesters and copolymers formed therefrom, and processes for the preparation thereof from renewable resources.
    Type: Grant
    Filed: March 27, 2009
    Date of Patent: July 2, 2013
    Assignee: Imperial Innovations Limited
    Inventors: Charlotte K. Williams, Molly Morag Stevens, Min Tang
  • Publication number: 20110142902
    Abstract: The present invention relates to a glass composition formulated to provide the controlled release of certain transition metal ions to regulate the cellular hypoxia pathway and the use of these hypoxia-pathway regulating glasses in medicine and in biomedical research, including in the repair, restoration or regeneration of diseased or damaged tissue.
    Type: Application
    Filed: May 27, 2009
    Publication date: June 16, 2011
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: Gavin Jell, Robert Graham Hill, Molly Morag Stevens, Maria Azevedo
  • Publication number: 20110077380
    Abstract: The present invention relates to a novel carbohydrate lactone, functionalized aliphatic polyesters and copolymers formed therefrom, and processes for the preparation thereof from renewable resources.
    Type: Application
    Filed: March 27, 2009
    Publication date: March 31, 2011
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: Charlotte K. Williams, Molly Morag Stevens, Min Tang
  • Publication number: 20110045052
    Abstract: The present invention relates to bioactive glass coatings. In particular, the present invention relates to bioactive glass coatings for Ti6Al4V alloys and chrome cobalt alloys, wherein the thermal expansion coefficient of the glass coating is matched to that of the alloy. Such coatings have a particular application in the field of medical prosthetics. The bioactive glass comprises (in mol %) 35-53 SiO2; 2-11 Na20; at least 2% of each of CaO, MgO and K20; 0-15 ZnO; 0-2 B202 and 0-9 P205.
    Type: Application
    Filed: December 19, 2008
    Publication date: February 24, 2011
    Applicant: IMPERIAL INNOVATIONS LTD.
    Inventors: Robert Graham Hill, Molly Morag Stevens, Matthew O'Donnell
  • Publication number: 20110009511
    Abstract: The present invention relates to glass compositions for use in formation of polycarboxylate cements and polycarboxylate cements comprising these glasses, wherein the glasses comprise SiO2 and MgO, with a molar percentage of SiO2 not exceeding 60% and a molar percentage of MgO being greater than 20%.
    Type: Application
    Filed: July 2, 2008
    Publication date: January 13, 2011
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: Robert Graham Hill, Molly Morag Stevens
  • Publication number: 20090208428
    Abstract: The present invention relates to a bioactive glass comprising strontium and silicon dioxide, processes for the production of the bioactive glass and the use of the bioactive glass in medicine.
    Type: Application
    Filed: June 15, 2007
    Publication date: August 20, 2009
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: Robert Graham Hill, Molly Morag Stevens